Yoonkyung Park Selected Research

Yoonkyung Park Research Topics

Disease

20	Infections 01/2023 - 11/2006
8	Inflammation (Inflammations) 08/2022 - 08/2011
5	Bacterial Infections (Bacterial Infection) 12/2023 - 01/2011
5	Neoplasms (Cancer) 03/2018 - 07/2002
5	Hemolysis 06/2012 - 02/2005
3	Communicable Diseases (Infectious Diseases) 10/2022 - 04/2002
3	Gallstones (Gallstone) 09/2010 - 08/2004
2	Muscle Cramp (Cramp) 12/2022 - 03/2021
2	Septic Shock (Toxic Shock Syndrome) 10/2022 - 01/2016
2	Wounds and Injuries (Trauma) 12/2018 - 10/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2018 - 01/2014
2	Cholelithiasis 01/2014 - 09/2010
2	Virus Diseases (Viral Diseases) 11/2006 - 06/2006
1	Cross Infection (Nosocomial Infection) 12/2023
1	Sepsis (Septicemia) 12/2023
1	Fibrosis (Cirrhosis) 12/2023
1	Herpes Zoster 12/2022
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2022
1	Hepatitis B 08/2022
1	Chronic Hepatitis B 08/2022
1	Abscess 10/2021
1	Staphylococcal Infections 10/2021
1	Rheumatoid Arthritis 03/2021
1	COVID-19 12/2020
1	Vascular Calcification 03/2019
1	Rupture 01/2019
1	Pseudomonas Infections 12/2018
1	Skin Diseases (Skin Disease) 03/2018
1	Necrosis 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2018
1	Burns 10/2017
1	Body Weight (Weight, Body) 01/2016
1	Tuberculosis (Tuberculoses) 01/2015
1	Acne Vulgaris 01/2015
1	Gastritis 01/2014

Drug/Important Bio-Agent (IBA)

20	Antimicrobial PeptidesIBA 12/2023 - 08/2004
18	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 07/2002
18	Peptides (Polypeptides)IBA 12/2022 - 04/2002
4	CytokinesIBA 12/2023 - 11/2018
4	Proteins (Proteins, Gene)FDA Link 08/2022 - 11/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 11/2018
3	Carbapenems (Carbapenem Antibiotics)IBA 12/2023 - 01/2022
3	Interleukin-6 (Interleukin 6)IBA 10/2021 - 10/2017
3	Adenosine Monophosphate (AMP)IBA 10/2017 - 01/2014
2	Adenosine Triphosphatases (ATPase)IBA 12/2022 - 12/2021
2	Peptide Hydrolases (Proteases)FDA Link 12/2022 - 02/2012
2	CathelicidinsIBA 12/2022 - 03/2021
2	Anti-Infective Agents (Microbicides)IBA 10/2022 - 03/2018
2	AcidsIBA 12/2021 - 01/2006
2	Nucleic AcidsIBA 01/2020 - 01/2019
2	LigandsIBA 03/2019 - 01/2019
2	Ciprofloxacin (Cipro)FDA LinkGeneric 12/2018 - 01/2014
2	APTIBA 10/2017 - 10/2016
2	ribosomal protein L1IBA 06/2012 - 01/2006
1	barium chloride (barium dichloride)IBA 12/2022
1	CalpainIBA 12/2022
1	CardiotoxinsIBA 12/2022
1	Hemolysin Proteins (Hemolysins)IBA 08/2022
1	Protein AggregatesIBA 08/2022
1	Hepatitis B e AntigensIBA 08/2022
1	hylinIBA 08/2022
1	Oxacillin (Prostaphlin)FDA LinkGeneric 01/2022
1	Nitric Oxide Synthase (NO Synthase)IBA 10/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2021
1	Cell-Penetrating PeptidesIBA 10/2021
1	Small Interfering RNA (siRNA)IBA 03/2021
1	VaccinesIBA 12/2020
1	A-factor (Streptomyces)IBA 11/2019
1	OsteoprotegerinIBA 03/2019
1	pleurocidinIBA 02/2019
1	InterferonsIBA 11/2018
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 11/2018
1	EndotoxinsIBA 04/2018
1	TubulinIBA 03/2018
1	ElastinIBA 03/2018
1	CollagenIBA 03/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 01/2018
1	Tigecycline (Tygacil)FDA Link 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	Proteasome InhibitorsIBA 01/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2018
1	Interleukin-8 (Interleukin 8)IBA 10/2017
1	Nucleotide AptamersIBA 10/2017
1	GoldIBA 10/2017
1	LipopolysaccharidesIBA 01/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 11/2015
1	AnticoagulantsIBA 03/2015
1	CarbohydratesIBA 03/2015
1	AntioxidantsIBA 03/2015
1	Antimalarials (Antimalarial Agents)IBA 01/2015
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Ampicillin (Omnipen)FDA LinkGeneric 01/2014
1	NF-kappa B (NF-kB)IBA 01/2014
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2014
1	Cefotaxime (Kendrick)FDA LinkGeneric 01/2014
1	Erythromycin (Erycette)FDA LinkGeneric 01/2014

Therapy/Procedure

2	Therapeutics 10/2016 - 01/2015
1	Intra-Articular Injections 03/2021